Astronova SEC Filings

The filing reports that Thomas D. DeByle, Chief Financial Officer of AstroNova, Inc. (ALOT), was granted 87,260 restricted stock units (RSUs) on August 15, 2025. Each RSU represents the right to one share of common stock and the units vest and will settle on August 15, 2028. The reported grant has a reported price of $0 because RSUs are rights to future shares rather than a cash purchase. Following the grant, 87,260 shares are reported as beneficially owned in a direct form. The Form 4 was signed by power of attorney on behalf of the reporting person on August 19, 2025.

AstroNova, Inc. (ALOT) Form 4: Reporting person Jorik Ittmann, who is both a director and the Chief Executive Officer, was granted 130,890 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to receive one share of ALOT common stock. The RSUs vest and will settle on August 15, 2028. Following the reported transaction the filing shows 130,890 shares beneficially owned, held directly, with a reported price of $0 for the award. The Form 4 was signed on behalf of the reporting person by power of attorney on 08/19/2025.

Insider award of restricted stock units to a company officer Thomas Carll (reported as a Senior Vice President and officer) was granted 43,630 restricted stock units of AstroNova, Inc. (ALOT). Each restricted stock unit represents a contingent right to receive one share of common stock, with the units set to vest and settle on August 15, 2028. The report shows the transaction as an acquisition with a reported price of $0, and the amount of common stock beneficially owned following the transaction is 43,630 shares held directly. The Form 4 was submitted under Section 16 reporting rules and was signed by power of attorney on behalf of the reporting person.

AstroNova, Inc. (ALOT) reporting person Michael J. Natalizia, Chief Technology Officer, was granted 21,815 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to one share of common stock and the award carries a $0 per-share exercise/price indicator because these are restricted stock units rather than purchases. The RSUs vest and settle on August 15, 2028, and following the grant Mr. Natalizia beneficially owns 21,815 shares directly attributable to this award. The Form 4 was filed as an individual report and was signed via power of attorney on 08/19/2025.

AstroNova (ALOT) filed an Item 5.02 Form 8-K announcing a leadership transition. On 31 Jul 2025 the Board promoted Senior VP Product Identification Jorik Ittmann (47) to President & CEO and director, effective 15 Aug 2025. Interim CEO Darius G. Nevin becomes Executive Chairman.

Key employment terms for Mr. Ittmann

• Base salary $360k.
• Target bonus 70 % of FY-26 salary linked to Revenue 25 %, Adj. Operating CF 25 %, Adj. EBITDA 50 %.
• Performance stock award: reference value $115,753.
• Time-based RSU grant worth $1.5 m; cliff vest 15 Aug 2028 with pro-rata or Triggering-Transaction acceleration.
• Up to 52-week salary continuation if terminated without cause before Aug-2028; none on change-in-control with shareholder payout.

Compensation adjustments for other executives (effective 15 Aug 2025)

• CFO Thomas DeByle salary $425k; Tom Carll & Michael Natalizia $280k each.
• Target bonuses: 70 %, 45 %, 45 % of salary, respectively.
• Performance awards of $82,185; $11,112; $12,964 and RSUs of $1.0 m; $0.5 m; $0.25 m, mirroring CEO terms.

No financial results were disclosed.

AstroNova (ALOT) Form 8-K – CEO Separation Agreement

AstroNova filed a Current Report to document the final terms governing the departure of former President & Chief Executive Officer Gregory A. Woods, whose resignation was previously announced on 29 Jun 2025. Mr. Woods’ employment and board service ended on 16 Jul 2025 under a Separation Agreement (Ex. 10.1).

• Severance: 50 % of current base salary and vehicle allowance for 52 weeks, paid bi-weekly.
• Equity: All unvested RSUs continue to vest for 12 months; listed stock options remain exercisable until the earlier of their 10-year grant anniversary or 16 Jul 2026.
• Benefits: Company subsidises 100 % of COBRA premiums for up to 12 months and reimburses Medicare premiums within a combined cap of $2,021.89 per month.
• Additional payments: Accrued PTO and pre-29 Jun 2025 business expenses paid on the next regular pay date.
• Obligations: Up to 20 hours per week transition assistance for one year and continued cooperation in MTEX New Solution S.A. acquisition proceedings.

No successor appointment, financial metrics or revised guidance were disclosed in this filing.